# China NMPA Product Recall - Tissue-reinforced stapler cartridge

Source: https://www.keypedia.com/records/china_product_recall/covidien-llc/7bf89be1-4d9a-4969-ad46-d86751e39541
Source feed: China

> China NMPA product recall for Tissue-reinforced stapler cartridge by Covidien llc published February 28, 2012. Recall level: . The National Medical Products Administration (NMPA) published a recall notice on February 28, 2012, 

---

## Details

- Record Type: CHINA_PRODUCT_RECALL
- Title: Covidien LLC is recalling its tissue-reinforced stapler cartridge.
- Company Name: Covidien llc
- Publication Date: 2012-02-28
- Product Name: Tissue-reinforced stapler cartridge
- Recall Reason: Covidien received a report of a missing part causing the staple cartridge to not fire fully, in which the surgeon had to extend the incision to remove the instrument. Another issue related to missing parts could prevent the instrument from opening completely, requiring manual intervention by the surgeon during use. Therefore, Covidien initiated this voluntary recall.
- Discovering Company: Covidien Medical Devices Trading (Shanghai) Co., Ltd.
- Manufacturing Company: Covidien llc
- Summary: The National Medical Products Administration (NMPA) published a recall notice on February 28, 2012, concerning Covidien LLC's tissue-reinforced staple cartridges for anastomosing devices. This voluntary recall was initiated by Covidien LLC, with its Chinese responsible unit being Covidien Medical Devices Trading (Shanghai) Co., Ltd., following a report received on February 20, 2012. The primary issue identified was the presence of missing parts within specific batches of the DUET6035A, 3.5MM Tissue-Reinforced Rotary Head Staple Cartridge, specifically batch number N1H0037LX. These missing components led to significant operational failures, including incomplete firing of the staple cartridge and instances where the instrument failed to open completely. Such malfunctions necessitated surgeons to prolong incisions or intervene manually during procedures, posing potential risks. While the recall primarily impacted markets in the USA and Latin America and did not involve the Chinese market, the NMPA requested its provincial and municipal food and drug administrations to enhance supervision of such medical products. Affected users in the relevant regions were instructed to immediately cease using the identified batch of staple cartridges, isolate any affected products, and return them directly to Covidien. This action underscores the regulatory commitment to device safety and quality assurance.

Company: https://www.keypedia.com/companies/covidien-llc/5111c5da-0a3d-4895-b59e-e49f0ad3547d